Tag Archives: EPA

27th European Congress of Psychiatry

The 27th European Congress of Psychiatry, organized by EBC member the European Psychiatric Association, will take place on 6-9 April 2019 in Warsaw, Poland.

The EPA Congress in 2019 is guided by the Congress motto, “Psychiatry in Transition – Towards New Models, Goals and Challenges”. EPA 2019 will facilitate discussion and educational forums on a range of topics in the field of psychiatry, psychology, social work and clinical trials.

EBC will be present in Warsaw with an exhibition stand (#26) and a joint EBC-EPA Symposium on the 9th of April (13:15 – 14:45, Hall A), co-chaired by EBC President Prof. Monica di Luca and incoming EPA President, Prof. Philip Gorwood. The session will cover “Parkinson’s Disease and Psychiatry”, featuring presentations by Prof. Fanni Geibl (Neuropsychiatric Symptoms in Prodromal and Early Parkinson’s Disease) and Prof. A. Leentjes (Depression: Risk Factor or Early Symptom in Parkinson Disease?).

Launch of ‘Sustainable Approach To Depression’ policy report

Today, the European Parliament Interest Group on Mental health, Well-being and Brain Disorders (with co-hosting MEPs Tomas Zdechovsky and Nessa Childers), EBC, GAMIAN-Europe, the European Psychiatric Association (EPA), EUFAMI, the Expert Platform on Depression, Eurocarers, the European College of Neuropsychopharmacology (ECNP), the UEMS – Sector of Psychiatry and the International Federation for Psychotherapy launch a joint policy paper on major depression, entitled ‘A sustainable approach to depression: moving from words to actions’, at the European Parliament in Brussels.

Today, over 35 million people are estimated to be living with depression in Europe Its cost is 30% higher than that of stroke. Yet as a society, we lack understanding of depression and empathy for those affected. Policies focused on depression exist, but implementation is variable and suffers from significant under-resourcing. This in turn contributes to significant gaps in diagnosis and care: only 25% of people diagnosed with depression receive appropriate and timely care.

These gaps need to be remedied – and require a comprehensive, sustainable policy response, looking at how to prevent and manage depression across all aspects of society.

The organisations listed above joined forces to address this need; they agreed to produce a report aimed at providing policymakers with concrete ways to better address the full spectrum of depression and its impact on our societies.  The report drew from the practical experiences of a variety of innovative projects addressing different aspect of depression across the EU. Key factors and lessons learnt were identified which can help policymakers develop and put in place concrete, relevant and sustainable policies and initiatives.

Today’s event aims to:

  • Present the key findings of this report;
  • Showcase examples of successful projects addressing depression;
  • Exchange views on how depression can be prioritized on the EU and national policy agendas;
  • Forge links between relevant stakeholders and explore ideas for future cooperation to ensure better management of depression.

A summary of the report is available below and the full report can be read and downloaded HERE.

A_sustainable_approach_to_depression_Summary

EBC attends the 25th European Congress of Psychiatry (Full Report)

From 1 – 4 April, EBC was pleased to attend the 25th European Congress of Psychiatry held by one of its members, The European Psychiatric Association (EPA), in Florence, Italy. Guided by the motto “Together for Mental Health,”  the congress facilitated learning, discussion, and exchange among European and international psychiatrists together with leaders of stakeholder organisations in mental health. A special focus of the EPA Congress was the dialogue between neurosciences and social sciences in the context of a psychiatry congress, overcoming the traditional separation between the domains of biology and human relationships, which has misled for too long the psychiatric and scientific professions and public opinion.​ The congress hosted an incredible range of speakers and leading experts in their fields, attending from all over Europe. The topics of discussion were also diverse and covered many aspects of psychiatry, ranging from “Gaming, gambling, behavioural addictions: Challenges in diagnosis and treatment​” and “Mental health care in refugees and asylum seekers” to ​​”Social media and e-mental health” and “Promoting mental health in the health and non-health sectors”.

Throughout the Congress, EBC welcomed Congress attendees to the exhibition booth, handing out the latest Value of Treatment Discussion Paper, the Call to Action and Consensus Paper, and the latest Joint Statement on Depression released on this year’s WHO World Health Day. Furthermore, details on EBC’s mental health at the workplace initiative, Not Myself Today, were available and countless people across the Congress were later spotted wearing the initiative’s iconic “Mood Buttons” proclaiming how they were feeling that day.

EBC was extremely pleased to contribute to the congress through a joint Symposium with EPA on EBC’s Value of Treatment (VoT) for brain disorders research project evaluating the treatment gap of mental and neurological brain disorders, where EBC President Prof. David Nutt and Vice-President Prof. Patrice Boyer presented EBC and the VoT project as a whole. Value of Treatment project experts Prof. Michela Tinelli of the London School of Economics (LSE) and Dr. Nick Guldemond of Erasmus University Rotterdam presented their work throughout the project, examining the Economic Analysis and costs of non-treatment and the Patient Journey, respectively. Lastly, Prof. Wolfgang Gaebel, Immediate Past President of the European Psychiatric Association (EPA) and Schizophrenia Working Group member, presented the preliminary results of the work completed in his particular working group.

 

EBC attends 25th European Congress of Psychiatry, Florence (04.17)

From 1 – 4 April, EBC was pleased to attend the 25th European Congress of Psychiatry held by one of its members, The European Psychiatric Association (EPA), in Florence, Italy. Guided by the motto “Together for Mental Health,”  the congress facilitated learning, discussion, and exchange among European and international psychiatrists together with leaders of stakeholder organisations in mental health. A special focus of the EPA Congress was the dialogue between neurosciences and social sciences in the context of a psychiatry congress, overcoming the traditional separation between the domains of biology and human relationships, which has misled for too long the psychiatric and scientific professions and public opinion.​ The congress hosted an incredible range of speakers and leading experts in their fields, attending from all over Europe. The topics of discussion were also diverse and covered many aspects of psychiatry, ranging from “Gaming, gambling, behavioural addictions: Challenges in diagnosis and treatment​” and “Mental health care in refugees and asylum seekers” to ​​”Social media and e-mental health” and “Promoting mental health in the health and non-health sectors”. EBC was extremely pleased to contribute to the congress through a joint Symposium with EPA on EBC’s Value of Treatment (VoT) for brain disorders research project evaluating the treatment gap of mental and neurological brain disorders.

 

For more information on VoT, click here.

For more information on EPA Congress, click here.

A full report on the congress will be released soon.

 

 

 

Brain Awareness Week: Outreach Event, Strasbourg (16.03.17)

What is Brain Awareness Week?

The global campaign to increase public awareness of the progress and benefits of brain research

Brain Awareness Week unites the efforts of partner organizations from around the world in a week-long celebration of the brain every March. Partners organize creative and innovative activities in their communities to educate and excite people of all ages about the brain and the promise of brain research.

Brain Awareness Week was founded in 1996 by the Dana Alliance for Brain Initiatives. EBC partner, The Federation of European Neuroscience Societies (FENS) joined the celebrations in 2006, administering the grants that the Dana Foundation reserves for participating European organisations.

“Now in its 22nd year, Brain Awareness Week continues to flourish because of participation of partners from around the globe, like FENS, and their commitment to educating the public about the importance of brain research and its critical role in helping people lead healthier, more productive lives.” – Edward Rover, Chairman, The Dana Foundation & The European Dana Alliance.

Find out about Brain Awareness Week in France here.

As part of Brain Awareness Week, EBC, in collaboration with The Dana Foundation, The Belgian Brain Council, The European Psychiatric Association (EPA) and The Federation of European Neuroscience Societies (FENS), organized an outreach event at the European Parliament, Strasbourg on 16 March 2017. The title of the event “Expanding Brain Research in Europe:  A societal Need?” was in parallel to the Lunch debate organized in Brussels on 14 March 2017. The goal of the event was to target MEPs and other decision makers interested in the fields of health, research and innovation. The event was hosted by MEP Anne Sander and MEP Momchil Nekov

          

The event at Strasbourg consisted of three presentations given by guest speakers: Monica DiLuca, Professor of Pharmacology at the University of Milano and Vice President of EBC,  Marion Leboyer, M.D., Ph.D. is currently Professor of Psychiatry at the University of Paris Est (UPEC) in France and Anne Little,  President of The European Federation of Neurological Associations (EFNA) and Executive Director of The International Bureau for Epilepsy.

The event was highly successful, with a good showing of policymakers, researchers and the general public who openly interacted with each other and the speakers during the hour of open discussion following the presentations.

The abstracts of each presentation are below:

Monica DiLucaBrain Research in Europe: Our Challenge for the Future

Brain diseases represent a considerable social and economic burden in Europe. With yearly costs of about 800 billion euros and an estimated 179 million people afflicted in 2010, brain diseases are an unquestionable emergency and a grand challenge for neuroscientists. Considering the costs of brain diseases for the European society, and considering that these costs will increase considerably in the coming years due to the ageing European population, one way of curbing this increase and possibly decreasing the costs is via intensified research. Thus, strong basic research in neuroscience and the development of a strong European platform for neuroscience is needed to face brain diseases, which nowadays represent a societal emergency in European countries.

 

Ann Little— Putting neurology patients at the heart of research

Patients should be involved in helping to shape priorities for research that is ultimately carried out for their benefit. A growing body of evidence suggests that involving patients in research improves the relevance, quality and speed of that research. Furthermore, including patients as top level priorities in order to close the gap between what researchers want to research and what patients want researching is likely to be beneficial for all research.

The Value of Treatment project initiated by the European Brain Council is one excellent example of patient participation in research. The project addresses the burden of disease and the issues in the current healthcare system, and proposes evidence-based and cost-effective solutions to achieve high value for patients. By describing (“mapping”) the patient journey in full detail (by both patients and health care professionals), treatment gaps have been identified which will be addressed in the policy recommendations resulting from this project.

Marion Leboyer— Supporting research in psychiatry in Europe: A major societal issue

Mental disorders represent the single greatest economic and social burden on European society. The cost of mental disorders (excluding dementia and other organic brain disorders) in 2010 was estimated at €461 billion. This is the lowest current estimate for this figure, as it does not take into account the large additional costs associated with having co-occurring mental and physical disorders.

With sufficient investment, mental health research could address the burdens in Europe, especially through research on prevention of mental disorders in young or at-risk populations, on improvement of understanding of causes, on developing new tools for diagnosis and innovative therapeutic strategies, thus promoting positive mental health in the general population. Such approaches have been advocated by the European Parliament and the European Commission, and Prof. Leboyer will outline the most pressing mental health research that takes advantage of Europe’s infrastructure and research strengths, including the EU ROAMER project.


On the evening before the outreach event, 15 March, a networking cocktail reception was also held by EBC member, The European Psychiatric Association (EPA) at their Strasbourg Headquarters.

      

 

A video containing the highlights of the event can be found on the EBC Youtube channel, and shared below: